AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Amgen (AVSOLA) (avsola.com)
AVSOLA presents a bifurcated profile: the medical content is high-substance and low-BS, while the corporate branding is high-fluff. The score of 40 reflects a site that is legally required to be honest about its product but chooses to be generically vague about its brand authority.
Implement Organization and Physician schema to provide a verifiable digital footprint for the brand and associated experts. Replace vague headers like THE AMGEN EXPERIENCE YOU CAN TRUST with specific nouns, such as 40 Years of Biomanufacturing Data. Link all superscript citations directly to their entries on ClinicalTrials.gov or PubMed to provide a clear proof path. Add specific manufacturing certifications (e.g., ISO 13485) to the Amgen Expertise page to ground the quality control claims in objective standards.
The site exhibits a high substantive ratio overall due to the density of FDA-mandated safety information and clinical indications. However, the marketing headings are significantly fluff-saturated, using power phrases like THE AMGEN EXPERIENCE YOU CAN TRUST and REAL-WORLD EXPERIENCE AND EXPERTISE PAVED THE WAY without specific metrics in the headers. Body text between the clinical data is often generic, repeating the Amgen leadership value proposition at least four times across the four pages analyzed.
A site without a coherent link graph forces AI to guess which pages matter. Reveal your real semantic graph and see how your domain is actually mapped by machine logic.
There is minimal semantic drift between the homepage signal and sub-page substance. The homepage H1 promises a trustworthy experience from Amgen, and the sub-pages, specifically the Totality of Evidence page, deliver on this by providing technical study designs, efficacy results, and pharmacology data. The intent to serve both patients and healthcare professionals (HCPs) is consistently maintained across the navigation and content structure.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The site triggers trust theatre flags because multiple pages report a review_count (2 on homepage, 4 on the Totality of Evidence page) while maintaining a proof_links_count of 0. This suggests that testimonials or data points are presented without direct outbound links to verifiable third-party sources like ClinicalTrials.gov or PubMed. Large claims regarding Amgen’s leadership and the rigors of their quality control are stated as fact without direct linkable evidence to manufacturing certifications in the provided text.
The proof density is high for medical efficacy but low for corporate methodology. Clinical assertions regarding indications for Crohn’s Disease and Rheumatoid Arthritis are supported by multicenter studies (referenced via superscripts), but claims about the Amgen Experience and rigorous quality control measures remain vague assertions without specific ISO or GMP certification numbers listed in the crawled data.
For a demonstration of entity driven retail architecture, open the Walmart Structured Data audit. View the Walmart Structured Data Audit to see how product, brand, and service entities are reconstructed for AI systems.
The site uses several industry cliches including biotech leader, science-driven, and proven leader. While the value proposition is drug-specific and thus unique, the framing of the company’s authority is highly templated. Sections like HELPFUL RESOURCES FOR YOU THROUGHOUT YOUR TREATMENT JOURNEY are standard boilerplate for pharmaceutical patient-education sites and offer little differentiation in tone.
A significant authority gap exists in the technical implementation: the schema_json is null across all pages, which is unexpected for a high-authority global biotechnology brand. While the brand Amgen is a verifiable entity, the site fails to use structured Person schema to connect its claims of expertise to specific scientists or leaders. The technical credibility is slightly undermined by this lack of modern structured data to support its leadership positioning.
The performance claims for the drug (e.g., inducing and maintaining clinical remission) are heavily substantiated by regulatory definitions and indications. The disconnect occurs mainly in the corporate performance claims, such as being a long-standing biotechnology leader committed to developing the marketplace, which lacks specific market share numbers or growth data to back up the pioneered leadership claim.
Medical Devices, Pharma & Biotech BS: Amgen (AVSOLA) (avsola.com)
The content perfectly aligns with the Medical Pharma & Biotech category. It focuses on AVSOLA (infliximab-axxq), a biosimilar drug, and provides the heavy regulatory documentation required for this industry, such as Boxed Warnings and Important Safety Information.
AI cannot build a coherent graph if the same page resolves into multiple identities. Explore the URL & Canonical Hygiene Technical Framework to understand how identity stability prevents duplicate embeddings and semantic drift.
“The score was primarily driven by the trust_and_proof pillar (13/20) due to the presence of unverified reviews and the identity_and_authority pillar (10/15) due to the complete absence of schema data. The high substance of the clinical information kept the information_density score relatively low for a corporate site.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 29, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Amgen (AVSOLA) to view the most current version of their content and see directly what the company offers.